Barramundi Limited has provided its February 2023 monthly update.
Update includes: - commentary from Barramundi Portfolio Manager - performance to 31 January 2023
See moreThe S&P/NZX 50 Index closed up 0.17% or 22.50 points.
Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than...
Rod Duke expects full-year profits to come in lower than previously signalled.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details